Viewing StudyNCT05962502



Ignite Creation Date: 2024-05-06 @ 7:18 PM
Last Modification Date: 2024-10-26 @ 3:04 PM
Study NCT ID: NCT05962502
Status: RECRUITING
Last Update Posted: 2023-08-31
First Post: 2023-07-17

Brief Title: Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy
Sponsor: Sun Yat-sen University
Organization: Sun Yat-sen University

Conditions & Keywords Data

Conditions:
Name
Metastatic Colorectal Cancer
Keywords:
Name View
Third-line therapy View
NeoRAS wild-type View
mCRC View
Cetuximab View